Viral Proteomics
Hepatitis B virus X protein triggers survival signals by activating enzyme
Published in Hepatitis Weekly, October 6th, 2003
"We have previously shown that transactivation-proficient hepatitis virus B X protein (HBx) protects Hep 3B cells from transforming growth factor-beta (TGF-beta)-induced apoptosis via activation of the phosphatidylinositol 3-kinase (PI 3-kinase)/Akt signaling pathway. This work further investigated how HBx activates PI 3-kinase. Src activity was elevated in Hep 3B cells following expression of transactivation-proficient HBx or HBx-green fluorescent protein (GFP) fusion proteins," according to researchers in Taiwan."
"The Src family kinase inhibitor PP2 and C-terminal Src...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-10-06)
More Articles from Hepatitis Weekly
- Hepatitis C Diagnosis
The MagNA pure LC reduces laborious HCV sample preparation - Viral Genomics
The INNO-LiPA assay can quickly identify hepatitis B virus variants - Antiviral Therapy
Limitin is similar to but distinct from interferon-alpha as hepatitis C therapy - Chronic Hepatitis C
Adenovirus-mediated interferon-alpha gene transfer blocks HCV replication - Liver Disease
Thioredoxin transfection protects liver cells from apoptosis and necrosis - Zoonosis
Subclinical hepatitis E virus prevails among humans and swine in Korea - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
